Embolization with MVP (Micro Vascular Plug®): experience on 104 patients in emergent and elective scenarios.

Francesco GiurazzaAnna Maria IerardiAndrea ContegiacomoFabio CorvinoGiampaolo CarrafielloRaffaella Niola

Published in: CVIR endovascular (2021)

MVP is a safe and effective embolic agent. While eventual concomitant anticoagulation therapy did not influence the technical outcome, straight course and length of the landing zone are essential parameters to evaluate before deployment.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
climate change
atrial fibrillation
venous thromboembolism
peritoneal dialysis
prognostic factors
stem cells
patient reported outcomes
cell therapy